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Method and neuroprosthetic device for monitoring and sup 
pression of pathological tremors in a user through the neuro 
stimulation of the afferent pathways to the brain, which com 
prises wearable elements placed over the parts of the body 
affected by tremor, wherein said wearable elements (1) have 
sensors selected from bioelectric sensors (3) generating a 
bioelectrical signal characterization of tremor, biomechanical 
sensors (4) generating a biomechanical signal characteriza 
tion of tremor and a combination thereof, a programmable 
electronic device (9) comprised of a control, acquisition and 
processing module of the characterization signals, and a sig 
nal generator for the afferent stimulation based on the bio 
electrical, biomechanical or combination of both signal char 
acterization and stimulation electrodes (8) which transmit the 
neuromodulation signals to the afferent pathways projecting 
into the central nervous system to modulate the activity of the 
neural structures responsible for tremor generation. 
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METHOD AND NEUROPROSTHETIC 
DEVICE FOR MONITORING AND 
SUPPRESSION OF PATHOLOGICAL 
TREMORS THROUGH 
NEUROSTIMULATION OF THE AFFERENT 
PATHWAYS 
OBJECT OF THE INVENTION 
[0001] The present invention relates to a method and a 
neuroprosthetic device for monitoring and suppression of 
pathological tremor in a user via the stimulation of peripheral 
afferent pathways. The resulting afferent in?ow projects into 
the central nervous system (spinal cord and brain) where it 
modulates the activity of the neural structures responsible for 
generating/maintaining pathological tremor. Therefore, with 
this method and device, functional compensation (i.e., attenu 
ation) of the pathological tremor by the stimulation of the 
afferent pathways is achieved, in particular in the upper limbs. 
[0002] The main ?elds of application of the present inven 
tion are the methods, material and electronic equipment 
within the orthopro sthetic and rehabilitation industries. 
BACKGROUND OF THE INVENTION 
[0003] Pathological tremor can be de?ned as a strong invol 
untary oscillatory movement of a body part. Tremor is the 
most common movement disorder and its incidence and 
prevalence are increasing with the aging of the world popu 
lation, affecting 15% of people aged between 50 and 89 years. 
The most common are tremors caused by the two neurode 
generative diseases: Parkinson’s disease and Essential 
tremor. Although the disorder is not life-threatening, more 
than 65% of population suffering from upper limb tremor 
reports serious di?iculties inperforming the activities of daily 
living (ADL), greatly decreasing their independence and 
quality of life. The most common treatments are drug therapy 
or surgery. Patents and references described in this document 
are the current techniques for the treatment of tremor. How 
ever, 25% of patients do not bene?t from any of these treat 
ments, and this calls for the creation of alternative treatments 
to tremor. 
[0004] The pathological tremorsisimply referred to as 
tremors in the remainder of the documentiarise due to vari 
ous conditions. As a result, it is very dif?cult to differentiate 
tremors according to their etiology. Because their exact 
underlying mechanisms have not yet been clari?ed, none of 
them is fully understood. In the state-of-the-art, the tremors 
are treated with drug therapy or surgery, which may include 
thalamotomy or pallidotomy, or more commonly nowadays, 
thalamic stimulation (DB S). Unfortunately, both alternatives 
have signi?cant drawbacks: drugs often have side effects, and 
show a decrease in effectiveness over the years of use (01 
anow, C W et al. (2000) Preventing levodopa-induced dyski 
nesias, Ann Neurol 47, S167-S176; discussion 5176-168), 
while the DBS is associated with an increased risk of intrac 
ranial hemorrhage (~4% of patients) (Kleiner-Fisman, G, et 
al. (2006). Subthalamic nucleus deep brain stimulation: Sum 
mary and meta-analysis of outcomes, Mov Disord 21, S290 
S304) and psychiatric manifestations (Piasecki, S D et al. 
(2004) Psychiatric Complications of deep brain stimulation 
for Parkinson’s disease, J Clin Psychiatry 65, 845-849), 
moreover, the percentage of eligible patients is very low 
(Perlmutter, J S et al. (2006) Deep brain stimulation, Annu 
Rev Neurosci 29, 229-257), for example, only 1.6 to 4.5% of 
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the Parkinson’s disease patients (Morgante, L, et al. (2007) 
How many parkinsonian patients are suitable candidates for 
deep brain stimulation of subthalamic nucleus? Results of a 
questionnaire, Parkinsonism Relat Disord 13, 528-531). Fur 
thermore, the mechanisms accounting for the alleviation of 
tremor symptoms by drugs, thalamotomy or DBS are 
unknown, hampering the re?nement of the existing treatment 
forms, and the development of novel ones. 
[0005] Recently, the state-of-the-art has demonstrated the 
feasibility of managing upper limb tremors with biomechani 
cal loading, applied either through robotic exoskeletons, or 
transcutaneous neurostimulation. This approach, on the con 
trary to pharmacotherapy or surgery, suppresses tremors by 
the modi?cation of limb biomechanics, and not by targeting 
the site of tremor origin. In spite of attaining a systematic 
attenuation of moderate and severe tremors, there are a num 
ber of limitations in wearability, comfort, and selectivity 
(Rocon, E, et al. (2007) Design and validation of a rehabili 
tation robotic exoskeleton for tremor assessment and sup 
pression, IEEE Trans Neural Syst Rehabil Eng 15, 367-378). 
These techniques are protected by various patents: 
ES200301767, ES200402966, US. Pat. No. 5,562,707, and 
US. Pat. No. 6,959,215 US. Pat. No. 7,643,882B2. 
[0006] Recent experiments with subthreshold (afferent) 
transcutaneous stimulation carried out in the framework of 
TREMOR project (ICT-2007-224051) showed signi?cant 
tremor attenuation in a number of patients (unpublished 
results). This ?nding is in agreement with a recent work on 
restoration of locomotion in rodent models of Parkinson Dis 
ease through spinal cord stimulation (Fuentes, R, Peterson, et 
al. (2009) Spinal cord stimulation restores locomotion in 
animal models of Parkinson’s disease, Science 323, 1578 
1582). Therefore, current evidences support the idea that the 
stimulation of the afferent pathways may alleviate the symp 
toms of tremors, probably by a disruption of low-frequency 
synchronization in the corticobasal ganglia circuits (Fuentes, 
R, et al. (2010) Restoration of locomotive function in Parkin 
son’s disease by spinal cord stimulation: mechanistic 
approach, Eur J Neurosci 32, 1100-1108). 
[0007] Within the state-of-the-art, there are several patents 
that describe different techniques of stimulation but none 
protects the concept of this invention. The patent 
US20060217781A1 (Systems and methods for treating dis 
orders of the central nervous system by the modulation of 
brain networks) describes a series of methods and systems for 
the treatment of brain disorders through the neuromodulation 
of brain structures. The patent describes a number of methods 
for implementing neuromodulation (electrical, optical, mag 
netic or chemical stimulation) of the structures of the brain 
associated with the disease. Patent US20060212089 (Device 
for the desynchronization of neuronal brain activity) focuses 
on the description of a device for the desynchronization of 
brain areas. Importantly, all of the proposed techniques are 
focused on the direct stimulation of the brain and not on the 
stimulation of peripheral afferent pathways (sensory nerves), 
as described in this patent. The patent application 
US2011184489 entitled “Method of Treating Parkinson’s 
Disease and Other Movement Disorders” describes a method 
for the treatment of disorders associated with Parkinson’s 
disease based on electrical stimulation of the spinal cord. 
Patent WO2010141 155A1 entitled “Selective neuromodula 
tion using energy-ef?cient waveforms” describes methods 
for selective neuromodulation in mammals. 
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[0008] The patent application W02005122894 “Method 
and electronic computing device for suppressing and evalu 
ating tremors and spastic movements in relation to input and 
control peripherals” describes a method and device for dis 
cerning the tremor movement generated by neurological dis 
orders. 
DISCLOSURE OF THE INVENTION 
[0009] The present invention discloses a method and a neu 
roprosthetic device for monitoring and suppression of patho 
logical tremor in a user via neurostimulation of the peripheral 
afferent pathways (sensory nerves). This invention is 
employed as an alternative treatment to the reduction of 
tremor in patients suffering from the pathologies that gener 
ate tremor, in particular Essential tremor and Parkinson Dis 
ease. Its industrial application takes the form of a neuropros 
thesis (implanted or transcutaneous) to reduce the tremor 
through the neuromodulation of the afferent pathways. The 
?nal product therefore is a neuropro sthesis, integrating all the 
electronics for the control, acquisition and processing of 
tremor variables acquired by bioelectrical sensors (e.g., 
EMG) and/ or biomechanical movement sensors (e.g., inertial 
measurement units). This electronics is preferably integrated 
into a textile substrate to be worn on the human upper limb, 
with a set of electrodes (implantable or transcutaneous) for 
neurostimulation. The neuroprosthetic device, in addition to 
suppressing tremor, may be a tremor-monitoring tool during 
the patient’s daily life. Furthermore, the proposed method 
allows adapting automatically the neuromodulation strategy 
to the different conditions of tremor movement in each 
patient. 
[0010] A ?rst object of the present invention is a neuropros 
thetic device for monitoring and suppression of pathological 
tremor in a user via stimulation of the afferent pathways. This 
device is preferably portable. This concept could either 
replace or complement the traditional pharmacotherapeutic 
treatment of tremor. The stimulation is closed-loop controlled 
by a series of sensors that quantify the tremor of the person. 
The sensor data are processed and used to de?ne adequate 
levels and timing of the stimulation. 
[0011] As a result, the neuroprosthetic device comprises at 
least one part worn by the user and located on the part of the 
body affected by tremor. The part worn by the user may be 
preferably a textile garment and placed on the user’s arm or 
forearm, but it could also be placed on the other areas of the 
body. Each of the wearable elements comprises: 
[0012] At least one sensor selected from at least one 
bioelectrical sensor that generates a bioelectrical char 
acterization of tremor, at least one biomechanical sensor 
that generates a biomechanical characterization of 
tremor and a combination thereof; 
[0013] A programmable electronic device comprising at 
least one module for the control, acquisition and pro 
cessing of the electrical, biomechanical or both signal 
characterizations, and an electric signal generator for 
generating a signal of the afferent stimulation from the 
electrical, biomechanical or both characterization sig 
nals and, 
[0014] At least one stimulation electrode integrated into 
the wearable textile that transmits the signal for the 
stimulation to the afferent pathways. 
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[0015] In a particular implementation of the invention, each 
of the wearable elements comprises: 
[0016] At least one bioelectrical sensor that generates a 
bioelectrical characterization of tremor; 
[0017] At least one biomechanical sensor that generates 
a biomechanical characterization of tremor; 
[0018] A programmable electronic device comprising at 
least one module for the control, acquisition and pro 
cessing of the electrical and biomechanical signal char 
acterizations, and an electric signal generator for gener 
ating a signal of the afferent stimulation from the 
electrical and/ or biomechanical characterization signals 
and, 
[0019] At least one stimulation electrode integrated into 
the wearable textile that transmits the signal for the 
stimulation to the afferent pathways. 
[0020] The combination of at least one bioelectrical sensor 
and at least one biomechanical sensor provide additional 
input for online tremor detection and analysis. This can be 
used as a redundant input, making the device more robust. 
Additionally, the biomechanical sensors can provide infor 
mation when the bioelectrical sensors, such as EMG, cannot. 
For example, while the stimulation is being delivered (EMG 
corrupted by artifacts). 
[0021] In a particular implementation of the invention the 
neuroprosthetic device comprises at least one electroen 
cephalography sensor that measures brain activity and gen 
erates a signal that characterizes the intention of the user to 
move the limb affected by tremor. 
[0022] In another particular implementation of the inven 
tion, the device comprises an external device connectable to a 
programmable electronic device with an interface for access 
ing the functionalities of at least one wearable element. In a 
more particular implementation of the invention, the target 
programmable electronic device can be a computer, a tablet, 
a smartphone or a similar device. It is also envisaged that in 
another particular implementation of the invention, the exter 
nal device comprises means for displaying measurements 
taken by the neuroprosthetic device based on the acquired 
signals, a processor for analysis and generation of diagnostics 
and reports of tremor and a memory to store the measure 
ments performed by the neuroprosthetic device. 
[0023] In another particular implementation of the inven 
tion, the at least one stimulation electrode is an electrode 
selected between an implanted electrode (e. g., intramuscular 
wire electrode) and a transcutaneous electrode. 
[0024] In another particular implementation of the inven 
tion, the neuroprosthetic device comprises at least one bio 
electric sensor selected from a classic multichannel bipolar 
EMG, high-density electromyography sensors (hdsEMG), 
electroencephalography sensors (EEG), or a combination of 
those, measuring electrical activities of the muscles and brain 
and characterizing the pathological tremor and/ or voluntary 
movement intentions of the user. 
[0025] In another particular implementation of the inven 
tion, the neuroprosthetic device comprises at least one bio 
mechanical sensor is an inertial sensor selected from gyro 
scopes, accelerometers, magnetometers or a combination of 
those. 
[0026] In another particular implementation of the inven 
tion, at least one electromyography sensor is a multichannel 
thin ?lm electrode. 
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[0027] In another particular implementation of the inven 
tion, at least one stimulation electrode is a thin ?lm multi 
channel electrode. 
[0028] In another particular implementation of the inven 
tion, the connection between the programmable electronic 
device and the external device is selected from a wireless 
connection or a wired connection. 
[0029] In another particular implementation of the inven 
tion, the neuroprosthetic device as described in this patent 
application, further comprises a programmable electronic 
device selected from a computer, a smartphone and a tablet 
device, the connection between this programmable electronic 
device and the external device is selected from a wireless 
connection or a wired connection, and the external device 
comprises means for displaying measurements taken by the 
neuroprosthetic diagnostic device based on the available sen 
sors, a processor for analysis of tremor and generation of 
diagnostics and reporting, and a memory storage for the mea 
surements made by the neuroprosthetic device. 
[0030] Therefore, the present invention discloses an ambu 
latory neuroprosthesis, preferably wearable, to remotely 
monitor and treat tremor during the user’s daily life, where 
the neuroprosthesis integrates a neural stimulation and a high 
resolution measurement systems; these two components are 
integrated into the neuroprosthesis obj ect of this invention. As 
a result, with the measurement and stimulation systems inte 
grated into the neuroprosthetic device, the system allows to 
merge neural and biomechanical information to achieve a 
correct parameterization of tremor in everyday life, and use 
this information to control the closed-loop stimulation for 
tremor suppression. Additionally, this data will be interpreted 
in order to assess the tremor, and provide both to the neurolo 
gist and the individual patient the metrics re?ecting the cur 
rent status and evolution of the tremor. This will facilitate 
remote monitoring of treatment. In addition, the patient will 
get more involved in the therapy. It will also allow an obj ec 
tive comparison regarding a long-term drug therapy, which is 
the current gold standard for the tremor treatment. 
[0031] The neuroprosthesis concept provides a novel way 
to manage the involuntary movements in the part of the body 
affected by tremor. The system will be easy to use and self 
contained; this means that the acquisition, control electronics 
and power supply will be incorporated into the neuropros 
thetic device, providing functional treatment of the most 
common forms of tremor in upper limb, for instance, those 
caused by Parkinson and Es sential tremor. It will facilitate the 
independence of the patients, and maximize their time out of 
the care centers, saving costs associated with medical care. 
[0032] A second object of the present invention is a method 
of monitoring and suppression of pathological tremor in a 
user via the stimulation of peripheral afferent pathways, uti 
lizing the neuroprosthetic device described above. This 
method comprises the following steps: 
[0033] i) Tremor characterization by a plurality of sen 
sors selected from bioelectrical sensors generating a 
bioelectrical characterization signal, biomechanical 
sensors generating a biomechanical characterization 
signal and a combination thereof, wherein these tremor 
characterization signals comprise at least frequency, 
phase or amplitude of tremor; 
[0034] ii) To provide the programmable electronic 
device with these tremor characterization signals; 
[0035] iii) To distinguish the tremor from the voluntary 
movement of the user through a conventional analysis of 
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the bioelectrical characterization signal, the biome 
chanical characterization signal or the combination of 
bioelectrical and biomechanical characterization signal; 
[0036] iv) To calculate the neurostimulation control sig 
nal from the bioelectrical, biomechanical or both char 
acterization signals, which is implemented in the mod 
ule for control, acquisition and processing of the 
programmable electronic device; 
[0037] v) To generate the neurostimulation signal 
through the electronic signal generator (i.e., electrical 
stimulator) of the programmable electronic device and, 
[0038] vi) To send the stimulation signals to the plurality 
of neurostimulation electrodes that will stimulate the 
afferents pathways. 
[0039] In a particular implementation of the invention, the 
method of monitoring and suppression of patholo gical tremor 
in a user via the stimulation of peripheral afferent pathways, 
utilizing the neuroprosthetic device described above. This 
method comprises the following steps: 
[0040] i) Tremor characterization by a plurality of bio 
electrical and biomechanical sensors generating a bio 
electrical characterization signal and a biomechanical 
characterization signal wherein these tremor character 
ization signals comprise at least frequency, phase or 
amplitude of tremor; 
[0041] ii) To provide the programmable electronic 
device with these tremor characterization signals; 
[0042] iii) To distinguish the tremor from the voluntary 
movement of the user through a conventional analysis of 
the bioelectrical characterization signal and the biome 
chanical characterization signal; 
[0043] iv) To calculate the neurostimulation control sig 
nal from the bioelectrical and biomechanical character 
ization signals, which is implemented in the module for 
control, acquisition and processing of the pro grammable 
electronic device; 
[0044] v) To generate the neurostimulation signal 
through the electronic signal generator (i.e., electrical 
stimulator) of the programmable electronic device and, 
[0045] vi) To send the stimulation signals to the plurality 
of neurostimulation electrodes that will stimulate the 
afferents pathways. 
[0046] In another particular implementation of the inven 
tion, when the device has at least one electroencephalography 
EEG sensor which measures the brain activity of the user, the 
method further comprises the following steps: 
[0047] To add to the signals measured in step i) the user’ s 
brain activity as captured by at least one EEG sensor and 
generate an electroencephalography signal characteris 
ing the intended (voluntary) user movement of the body 
part affected by the tremor; 
[0048] To provide electroencephalography signals, in 
phase ii) to the control, acquisition and processing mod 
ule of the programmable electronic device; 
[0049] Additionally, to use electroencephalography sig 
nal in step iv) to calculate the neurostimulation signal to 
be sent to the neurostimulation electrodes for the activa 
tion of the afferents pathways. 
[0050] In another particular implementation of the inven 
tion, stimulation of the afferent pathways disrupts the low 
frequency synchronization in the corticobasal ganglia circuits 
of the user. 
[0051] In another particular implementation, the afferent 
in?ow generated by the stimulation of the peripheral afferent 
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pathways projects into the central nervous system (spinal 
cord and brain) where it modulates the activity of the neural 
structures responsible for generating/maintaining pathologi 
cal tremor. The latter will result with tremor attenuation. 
[0052] In another particular implementation of the inven 
tion, the analysis employed by the programmable electronic 
device for discriminating the tremor from the voluntary 
movement is based on algorithms in the time and frequency 
domain. More preferably, the algorithm used is the iterative 
Hilbert transform. An implementation of this type of signal 
analysis to differentiate tremulous from the voluntary move 
ment of the patient is described in the patent application 
W02005122894 (Method and electronic computing device 
for suppressing and evaluating tremors and spastic move 
ments in relation to input and control peripherals). However, 
one could employ any technique, which allows clear differ 
entiation of the signal generated by a tremor from the signal 
generated by a voluntary movement of a user that suffers from 
a neurological pathological condition. 
[0053] In another particular implementation of the inven 
tion, the programmable electronic device sets: 
[0054] The parameters of neuromodulation strategies to 
be executed, and 
[0055] The operating mode of the neuroprosthetic 
device. 
[0056] In another particular implementation of the inven 
tion the calculation of neurostimulation signal in the pro 
grammable electronic device is based on an algorithm in the 
frequency or time domain. More preferably, the algorithm in 
the frequency or time domain is selected from an IEEE-1057 
standard algorithm, a Kalman Filter and Benedict-Bordner 
?lter. 
[0057] Therefore, in summary, the proposed pathological 
tremor monitoring and suppression methods consist of two 
main stages: 
[0058] The ?rst stage is a strategy for identifying the char 
acteristics of the tremor from information gathered from a 
variety of biomechanical (inertial sensors) and/or physiologi 
cal (EMG or EEG signal) sensors. The features obtained by 
this strategy are at least the frequency, phase, amplitude of the 
tremor signal or a combination thereof. The method also 
allows differentiating the pathological tremor signal from the 
voluntary signal by means of any digital algorithm or any 
analog or digital electronic circuit designed for this purpose. 
Furthermore, information can be obtained on the cerebral 
activity, for example during preparation and initiation of a 
voluntary movement of the patient through the EEG signal. 
Additionally, the characteristics obtained from tremor may be 
used to monitor, track and log tremor during the patient’s 
daily life. 
[0059] The second stage consists of a control loop for the 
neuromodulation of afferent pathways, which uses the tremor 
information obtained in the previous phase, to de?ne the 
intensity and timing of electrical stimulation of the afferents 
pathways in order to relieve the symptoms of tremor, prefer 
ably, by interrupting the synchronization of tremor-related 
oscillations at spinal level or brain, thereby preventing the 
development of tremor. In this context, two possible control 
strategies are provided that can be implemented by the 
method and device object of this patent, both based on the 
neurophysiological tremor origin: 
[0060] A ?rst strategy is a desynchronization of the trem 
orogenic central network by means of afferent neuro 
stimulation. The rationale for this is that Essential 
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tremor and Parkinson’s disease are caused primarily by 
the brain structures that exhibit an abnormal oscillatory 
activity. Although a detailed description of such net 
works is still lacking, it is accepted that the desynchro 
nization of this abnormal activity is the mechanism that 
mediates tremor management with deep brain stimula 
tion, and also likely, through pharrnacotherapy. In addi 
tion, the delivery of afferent stimuli to the supraspinal 
centers from the periphery has recently been shown to 
improve the symptoms of Parkinson’s disease. The neu 
ro stimulator de?ned in this patent will directly stimulate 
the nerves innervating the tremulous muscles. This 
stimulation will be reaching the central tremorogenic 
network without interfering with other neural processes. 
To this end, the neurostimulator will stimulate in a range 
of frequencies aimed at causing the desynchronization 
of the tremor network. 
[0061] The second strategy is the decorrelation of the 
common input to motor neurons that innervate the 
affected muscles. This approach relies on the hypothesis 
that the desynchronization of the common tremor input 
to the motor neuron pool may reduce tremor amplitude. 
The rationale for this is that a secondary input, com 
monly projected to a pool of motor neurons, hampers the 
transmission of a primary inputiin this case the tremor. 
Indeed, this technique is based on today treatments 
known to alleviate the symptoms of Parkinson’s disease 
by vibrating the whole body. Interestingly, the experi 
ments showing that limb cooling reduces the severity of 
tremor arising from Parkinson’s disease, essential 
tremor, and multiple sclerosis, also provide support of 
this approach. 
[0062] Furthermore, by using an Internet connection, the 
neuroprosthetic device can send objective information for the 
physician to monitor in real time (online) the effects of treat 
ment for tremor suppression. 
[0063] The main advantages of the method and device 
objects of this invention compared to other techniques and 
devices within the state of the art could be summarized as: 
[0064] 
[0065] It is less invasive than DBS and the percentage of 
eligible patients is higher. 
[0066] It is the ?rst technique based on the afferent 
stimulation for minimiZing the tremor. This holds sev 
eral advantages with respect to the classical application 
of electrical stimulation where the muscles are activated 
to produce tremor canceling forces. Since in our 
approach the stimulation is below the motor threshold 
(afferent stimulation), the current intensities are lower, 
there is no signi?cant muscle contraction and the stimu 
lation is thereby more comfortable and does not produce 
muscle fatigue. 
[0067] The concept proposed in this patent will replace 
or complement the pharmacological treatment of 
tremor. 
[0068] The device will allow monitoring tremor of the 
patient under any treatment, which could be based on the 
neuroprosthetic device described in this document or 
conventional treatment (pharrnacotherapy or surgery). 
[0069] It does not limit the range of movements and 
freedom of the patient. 
It is portable and ambulatory. 
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BRIEF DESCRIPTION OF THE FIGURES 
[0070] FIG. 1.iIllustrates schematically the architecture 
of a particular implementation of the neuroprosthetic device 
de?ned in the present invention. 
[0071] FIG. 2.iIllustrates an example implementation of 
the device obj ect of the invention placed on a limb of a user. 
[0072] FIG. 3.iIllustrates an example implementation of 
the method for monitoring and suppression of pathological 
tremors de?ned in the present invention. 
[0073] FIG. 4.iIllustrates the components of the device 
presented in Example 1: (1) Bioelectrical sensor (i.e., EMG 
ampli?er and Ag/AgCl electrodes), (2) Programmable elec 
tronic device with processing module (i.e., standard laptop 
with custom-made control software) and acquisition module 
(i.e., USB data acquisition card), and (3) electronic signal 
generator (i.e., programmable stimulator). EMG from the 
wrist and ?nger ?exors and extensors was recorded, pro 
cessed to estimate tremorogenic activation, and the stimula 
tion was delivered to the same muscles out of phase with the 
tremorogenic bursts above and below the motor threshold. 
[0074] FIG. 5.iIllustrates the device operation of the 
device presented in Example 1. EMG from the wrist and 
?nger ?exors and extensors was recorded and used as input to 
an Iterative Hilbert Transform based algorithm estimating the 
tremorogenic EMG bursts. Based on this, the bursts that were 
expected to appear within the next stimulation window were 
predicted and the stimulation was delivered out of phase with 
the predicted EMG bursts. The rectangles in the ?gure are the 
steps of the algorithm, the full arrows represent the data ?ow, 
and the dashed arrows are the input parameters. The rectangle 
with a thick edge denotes the initial step. Notation: MIBIi 
mean inter-burst interval. 
[0075] FIG. 6A.iAn example of the ?exor processing pre 
sented in FIG. 5. This output is shown online to the device 
operator. 
[0076] FIG. 6B.iAn example of the extensor processing 
presented in FIG. 5. This output is shown online to the device 
operator. 
[0077] FIG. 7A.iWrist ?exion/extension joint angle 
recorded from subject ET1 while the device was active deliv 
ering the stimulation below the motor threshold [device on 
afferent stimulation]. The signals were created by concatenat 
ing data segments from several trials in the aforementioned 
conditions. 
[0078] FIG. 7B.iWrist ?exion/extension joint angle 
recorded from subject ET1 while the device was active deliv 
ering the stimulation above the motor threshold [device on 
motor stimulation]. The signals were created by concatenat 
ing data segments from several trials in the aforementioned 
conditions. 
[0079] FIG. 7C.iWrist ?exion/extension joint angle 
recorded from subject ET1 while the device was off [device 
off]. The signals were created by concatenating data segments 
from several trials in the aforementioned conditions. 
[0080] FIG. 8.iWrist ?exion/ extension joint angle during 
stimulation below the motor threshold. Stimulation and 
recording windows are separated by the vertical dashed lines. 
As it is seen, tremor was attenuated during the stimulation 
with respect to the recording. The degree and consistency of 
suppression was however variable. 
[0081] FIG. 9A.iFrequency analysis of tremor suppres 
sion: power spectral density of the wrist angle signals 
recorded during the delivery of above motor threshold stimu 
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lation (motor stimulation). The plot (9A) compares the sys 
tem on (stimulation and recording together) versus system off 
conditions. 
[0082] FIG. 9B.iFrequency analysis of tremor suppres 
sion: power spectral density of the wrist angle signals 
recorded during the delivery of above motor threshold stimu 
lation (motor stimulation). The plot (9B) compares the tremor 
power for the signals recorded during the stimulation and 
recording time intervals separately with respect to the periods 
when the system was off. There was an overall suppression 
during above threshold stimulation and during both recording 
and the actual stimulation delivery. 
[0083] FIG. 9C.iFrequency analysis of tremor suppres 
sion: power spectral density of the wrist angle signals 
recorded during the delivery of below motor threshold stimu 
lation (afferent stimulation). The plot (9C) compares the sys 
tem on (stimulation and recording together) versus system off 
conditions. 
[0084] FIG. 9D.iFrequency analysis of tremor suppres 
sion: power spectral density of the wrist angle signals 
recorded during the delivery of below motor threshold stimu 
lation (afferent stimulation). The plot (9D) compares the 
tremor power for the signals recorded during the stimulation 
and recording time intervals separately with respect to the 
periods when the system was off. 
[0085] There was an overall suppression during below 
threshold stimulation and during both recording and the 
actual stimulation delivery. 
EXAMPLES 
[0086] This section provides a description of several imple 
mentations of the invention, with an illustrative and non 
limiting approach, making reference to the numbering 
adopted in the ?gures. 
[0087] FIG. 1 shows an implementation of the neuropros 
thetic device composed of the wearable garment (1), in this 
case textile, and the connectable external device (2) from 
where the operation of the neuroprosthesis and the tremor 
characteristics are monitored. 
[0088] This neuroprosthesis, which will be useful for moni 
toring, diagnosis and pathological tremor suppression in any 
of its variants, is being composed of the following compo 
nents: 
[0089] Wearable garment (1) that enables the integration 
of inertial sensors, and electronics for neurostimulation 
and electrophysiological signal acquisition and process 
ing, together with a module for data storage and com 
munication. This item (1) provide long-term records of 
neural and biomechanical data of the body part to which 
it is placed, and treats the tremor during the patient’s 
daily life by delivering the afferent stimulation. The 
collected information is analyzed, and derived metrics 
are extracted to provide both the patient and clinician 
with feedback of the therapy progress. The clinician will 
have remote access to this data, and will be able to adjust 
the therapy, and the user will be involved in the treat 
ment. 
[0090] Bioelectric sensors (3): 
[0091] a. Electrodes to measure surface (EMG) or 
intramuscular (iEMG) electromyography (6). These 
may be bipolar or high-density electrodes (6). 
[0092] b. Electrodes to measure electroencephalogra 
phy (EEG) (5) 
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The information from the bioelectric sensors may be 
useful for the management of control strategies for neu 
rostimulation. 
[0093] Motion sensors (4) such as inertial sensors 
(IMUS) (7) 
[0094] Electrodes (transcutaneous or implantable) for 
neurostimulation (8). 
[0095] Aprogrammable electronic device (9) which may 
be a microcontroller, microprocessor, DSP, . . . com 
puter, which is responsible for: 
[0096] a. The identi?cation and tracking of the tremor 
motion using appropriate state-of-the-art algorithms. 
[0097] b. The implementation of control algorithms 
for neurostimulation. 
[0098] c. The acquisition of the sensors signals (3, 4) 
of the wearable element (1). 
[0099] d. The generation of signals for neurostimula 
tion. 
[0100] e. Communication with an external device (2). 
The programmable electronic device (9) is able to 
communicate both wirelessly (Bluetooth, Zigbee, 
WiFi or erA) or through cable connection (TCP/IP, 
serial cable) with the external device (2). 
[0101] An external device (2) (PC, iDevice (iPhone, 
iPad), Smartphone or similar) responsible for: 
[0102] The implementation of an interface to access 
all the features of the neuroprosthesis. This interface 
allows: 
[0103] i. The adjustment of the parameters of the 
control strategies for neurostimulation. 
[0104] ii. The de?nition of the operation mode of 
the neuropro sthesis. 
[0105] iii. The presentation of the variables mea 
sured by the neuroprosthesis. 
[0106] iv. The analysis of the tremor motion. 
[0107] v. The presentation of the machine-based 
diagnostic. 
[0108] vi. The storage of the data acquired by the 
neuroprosthesis. 
[0109] vii. The preparation of reports. 
[0110] The communication (wirelessly or via a cable 
connection) with the neuroprosthesis. 
[0111] For the case in which the electrodes for neurostimu 
lation are implantable (8), all the electronics would be inte 
grated into the textile and only the electrode (intramuscular 
thin ?lm or wire) would be implanted in the muscle. For the 
case in which the electrodes for neurostimulation are trans 
cutaneous (8), all the electronics and the electrodes would be 
integrated into the textile. 
[0112] The programmable electronic device (9) comprises 
the entire electronic for control, acquisition and processing of 
the signals acquired by the sensors. The electronic device (9) 
is also running different calibration strategies for the control 
and suppression of tremor and it is capable of generating the 
appropriate signal for the afferent neurostimulation based on 
the information gathered by the sensors (3,4) and it is also 
able to communicate with the external device (2). This exter 
nal device (2), which is connected to the programmable elec 
tronic device (9), is able to provide an interface to access all 
the features of the neuroprosthesis (1) and present data in a 
convenient way to the users, who could be a patient or a 
clinician. 
[0113] The sensors, biomechanical and bioelectrical (3, 4), 
would be used to extract information about the patient’s 
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movement and, using the algorithms programmed into the 
neuroprosthesis, extract features of patient’s tremor. These 
tremor features allow customization of stimulation applied to 
each patient. 
[0114] The use of this neuroprosthetic device is twofold. 
On one hand, it can be used as a tool for tremor evaluation and 
objecti?cation in patients under normal conditions or under 
any tremor suppression treatment (pharmacological or surgi 
cal) and, on the other hand, as a tool for the treatment of these 
patients with tremors. 
[0115] FIG. 2 shows another implementation of the neuro 
prosthetic device object of the present invention in which the 
wearable garment is placed on the arm and forearm of a user. 
Therefore the wearable element (1), which in this case will be 
textile, integrates bioelectrical sensors (3), movement sensors 
(4), a programmable electronic device (9) and neurostimula 
tion electrodes (8). 
[0116] This example is based on the adoption of two gyro 
scopes as motion sensors (4). These sensors are integrated 
into a ?exible substrate, and are therefore very convenient for 
the integration within the garment. 
[0117] Both gyros are placed on the textile structure on both 
sides of the wrist joint and provide information about the 
absolute angular speed of the segments (hand and forearm) in 
the plane of motion of the joint. The sensors measure the 
frequency range between 0 and 50 HZ, thereby covering the 
entire frequency range of possible tremors. 
[0118] Bioelectric sensors (3) used in the example for the 
measurement of bioelectrical activity are the high-density 
multichannel thin ?lm iEMG electrodes. Electroencephalog 
raphy (5) (EEG) sensors are also used and are responsible for 
detecting the user’s voluntary intention to move. 
[0119] In the example, implantable thin ?lm electrodes (8) 
are used for neurostimulation and are responsible for the 
generation of electric ?elds that modulate the upper limb 
afferent pathways, projecting the afferent in?ow to spinal and 
supraspinal centers, thereby causing the interruption of the 
low frequency synchronization in corticobasal ganglia cir 
cuits and, consequently, the suppression of tremor. 
[0120] All algorithms used for cancellation of tremor could 
be implemented using programming environments that are 
suitable for the development of real time systems (e. g., C++). 
The algorithms are implemented in a microcontroller (inte 
grated in the programmable electronic device (9)) capable of 
capturing all the sensor signals. In this particular example the 
acquisition rate is 200 kHZ and the resolution 12 bits. This 
microcontroller also incorporates a Bluetooth module for 
wireless communication with the external device (2), not 
shown in the Figure. 
[0121] The strategy for identifying and monitoring the 
tremor is based on the signals from the sensors (bioelectrical 
(3) and biomechanical (4)). The EEG signal sensors provide 
the information about the patient intent to move voluntarily 
by integrating two Bayesian classi?ers that are based on 
different characteristics of the event related desynchroniza 
tion (ERD) in EEG signals. EMG sensors indicate the onset of 
tremor and ?nally, the amplitude and frequency of the tremor 
are extracted from the inertial sensor data. The sampling 
frequency chosen for the loop identi?cation is l KHZ. 
[0122] As external device (2) responsible for the imple 
mentation of the user interface is based on an iPad. The user 
interface is programmed into the iOS operating system. The 
communication between the programmable electronic device 
(9) and the external device (2) is made via Bluetooth. 
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[0123] The platform in this example provides long-term 
records of neural and biomechanical data of upper limb 
tremor. The tremor is treated during the patient’ s daily life by 
afferent nerve stimulation. The collected information is ana 
lyzed, and metrics are derived in order to provide the feed 
back about the performance of the therapy to the patient and 
the clinician. The remote medical professional has remote 
access to these data via the interface programmed in the iPad, 
and is able to adjust the therapy. As a result, the user is more 
involved in the treatment. 
[0124] The ?nal product will thus be an aesthetically 
appealing wearable neuroprosthesis that will integrate all the 
electronics for control, acquisition and processing, and the 
?exible inertial sensors on a textile substrate, together with a 
set of implantable thin ?lm electrodes for neurostimulation 
and neural recordings. The neuroprosthesis constitutes an 
alternative management of tremor, either alone or in combi 
nation with pharmacotherapy. 
[0125] FIG. 3 shows a particular example of the method for 
monitoring and suppression of pathological tremors in which 
biomechanical characterization signals (12), captured by the 
inertial sensors (4), bioelectrical characterization signals 
(13), captured by the electromyography sensors (3) and elec 
troencephalography sensors (14) are sent to the program 
mable electronic device (9) which differentiate (15) the 
tremor (16) from the voluntary movement (17) of the user. 
This operation is performed in the control acquisition and 
processing module (10) of the electronic device (9). From the 
characterization of tremor signal (16) the control module (10) 
calculates (18) the necessary neurostimulation to compensate 
the tremor (16). This signal is sent to neurostimulation signal 
generator (11), generating (19) this signal and sending it to 
the neurostimulation electrodes (8) that eventually generate 
(20) the afferent in?ow to the central nervous system. 
Example 1 
[0126] In this example we present one particular imple 
mentation of the method and device object of this invention 
that was tested in patients as a proof-of-the-concept. The tests 
demonstrated that indeed afferent stimulation can be used to 
suppress tremor. 
[0127] The device estimates tremor from the recorded 
EMG signals online by using an algorithm based on the 
Iterative Hilbert Transform (IHT) that we described previ 
ously in an o?iine implementation (J . L. Dideriksen et al. 
(201 1) EMG-Based Characterization of Pathological Tremor 
Using the Iterated Hilbert Transform, IEEE Transactions on 
Bio-Medical Engineering, vol. 58, no. 10, pp. 2911-2921). 
Stimulation was delivered over the motor points of the wrist 
and ?nger ?exors and extensors out of phase with respect to 
the tremulous EMG activity. The device was tested in 6 
tremor patients and the results with afferent stimulation were 
compared to those obtained in the same patients using the 
stimulation above the motor threshold (motor stimulation), 
considered as the reference standard (classical approach). 
A. Device Components (Hardware) 
[0128] The neuroprosthetic device comprised the follow 
ing components (FIG. 4): 1) Bioelectrical sensor i.e., an EMG 
ampli?er (AnEMG12, OTBioelettronica, IT) with two analog 
bipolar channels and standard 2111 mm Ag/AgCl electrodes 
(Neuroline 720, Ambu, DK), 2) Programmable electronic 
device with processing module (standard laptop, dual core at 
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2 GHz), acquisition module (NI USB 6210, National Instru 
ments, US), and electric signal generator, i.e., stimulator 
(TremUNA, UNA Systems, SR). Bioelectric sensors were 
used to detect EMG from the wrist and ?nger ?exors and 
extensors. The ampli?er channels with adjustable gains were 
equipped with analog band-pass ?lters with the cut-off fre 
quencies at 10 and 500 Hz. The EMG signals were sampled at 
1 kHz by the data acquisition card connected via a USB port 
to the laptop. The laptop ran custom-made software for 
tremor suppression, which controlled the acquisition, pro 
cessed the EMG data and commanded the stimulation unit, as 
described in “B. Device operation (see below)”. The stimu 
lator was battery powered, current-controlled and fully pro 
grammable; it was connected to the laptop via USB, through 
which it received textual commands allowing the online con 
trol of the stimulation timing and intensity. The USB com 
munication components were optically isolated from the rest 
of the stimulator electronics. Four stimulation channels in 
monopolar electrode con?guration (common anode) were 
used to activate wrist and ?nger ?exor and extensor muscles. 
Disposable square (5 cm><5 cm) and round (1213.2 cm) elec 
trodes (PALS Platinum, Axelgaard, US) were used for the 
stimulation of the wrist ?exors/extensors and ?nger ?exors/ 
extensors, respectively. Therefore, the device was suitable for 
the suppression of the ?exion/extension tremor. 
B. Device Operation 
[0129] The device implemented a sequential strategy, inter 
leaving recording and stimulation periods (FIGS. 4 and 5), 
i.e., the EMG was captured during the recording time win 
dow, the data were processed to determine tremor parameters 
and stimulation timing, and the stimulation was delivered 
during the stimulation time interval. This strategy was 
adopted in order to avoid the presence of stimulation artifacts 
in the EMG signals. The durations of the time windows can be 
easily adjusted by the skilled person. The aforementioned 
steps (i.e., recording, processing, and stimulation) were 
repeated in a loop. 
[0130] To estimate tremor parameters, we implemented 
online our recently developed method for tremor demodula 
tion based on the Iterative Hilbert Transform (IHT) (J. L. 
Dideriksen et al. (2011) EMG-Based Characterization of 
Pathological Tremor Using the Iterated Hilbert Transform, 
IEEE Transactions on Bio-Medical Engineering, vol. 58, no. 
10, pp. 2911-2921). The IHT was applied to the recti?ed 
EMG signal, and the ?rst IHT component band-passed 
between 3 and 12 Hz was an estimate of the tremorogenic 
EMG activity (separated from the voluntary component). If 
the root mean square of the demodulated tremor signal (FIG. 
5) was above a user de?ned threshold (i.e., tremor detection 
threshold), the tremor was deemed to be present. If the tremor 
was detected, the centers of tremorogenic EMG bursts were 
determined by ?nding the local maxima of the tremor signal. 
Only the maxima that were above the burst detection thresh 
old were taken into account. The thresholds for tremor and 
burst detection were selected by the skilled person. The mean 
inter-burst interval (MIBI) was then calculated, and the sub 
sequent tremorogenic bursts expected to appear within the 
stimulation window were predicted based on the calculated 
MIBI and the timing of the last recorded burst. This process 
ing was performed for each muscle group (?exor/extensor) 
independently. The stimulation was delivered out of phase 
with the estimated tremorogenic activity. The duration of the 
stimulation bursts was de?ned manually, by the skilled per 
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son, as a percentage of the MIBI, and the stimulation burst 
delivered to the ?exor (extensor) muscle coincided with the 
center of the predicted tremorogenic EMG burst of its antago 
nist, i.e., the extensor (?exor) muscle (out of phase stimula 
tion). The stimulation timing took into account the delays due 
to signal acquisition and processing. One example of the 
processing is given in FIG. 6A and FIG. 6B. In this particular 
example, the recording and stimulation windows were 1 sec 
ond long. FIG. 6A and FIG. 6B show the ?exor and extensor 
EMG, respectively, and the dashed line is the estimated 
tremor demodulated from the EMG. The stars denote the 
estimated centers of the tremorogenic bursts for the EMG 
captured during the recording window (tremor signal 
maxima), and the full black circles are the predicted centers of 
the tremorogenic bursts within the stimulation window. The 
dashed bars denote the time intervals during which the stimu 
lation bursts are delivered. The occurrences of the predicted 
bursts match very well those of the actual bursts within the 
stimulation window, and the stimulation was delivered out of 
phase with tremorogenic activation. 
C. Online Control Software 
[0131] The software for online con?guration and control of 
the neuroprosthetic device was developed in Visual C# (V1 
sual Studio, Microsoft, US), using Measurement Studio con 
trols (National Instruments, US), and implemented a user 
friendly interface for online device monitoring and setup. The 
main window comprised a Recording and Stimulation tab. 
The Recording tab included the ?elds for setting up the 
parameters controlling the EMG acquisition (e.g., sampling 
rate), tremor demodulation (i.e., the thresholds for tremor and 
burst detection) and device operation (e.g., duration of the 
recording and stimulation/prediction windows, stimulation 
burst duration in percent of MIBI). The Stimulation tab was 
used to select the stimulation channels, adjust the parameters 
(frequency, pulse width and amplitude) using sliders, and 
manually start and stop the stimulation on the speci?c chan 
nel (e.g., for testing the motor points). The device has two 
operating modes: monitoring and tremor suppression. In the 
former, the system records the data, displays the processed 
signals to the experimenter, and depicts the stimulation bursts 
graphically but without delivering the stimulation. This 
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Parkinson disease (PD). Inclusion criteria included predomi 
nant ?exion/extension tremor at the wrist. The characteristics 
of the recruited patients are reported in Table I. The experi 
ments were conducted in accordance with the Declaration of 
Helsinki and approved by the local ethical committee. All 
participants signed a written informed consent before the 
inclusion. 
E. Experimental Protocol 
[0132] The patients were comfortably seated in a chair in 
front of a desk. In the case of bilateral tremor, the neuropros 
thetic system was applied to the more affected side. The 
dorsal and volar sides of the forearm were gently cleaned with 
a wet sponge. The muscle motor points were identi?ed by 
using a probing electrode (i.e., stimulation electrode with a 
wet sponge on the top). The electrode was initially placed as 
recommended in (L. L. Baker, et al. (2000) Neuro Muscular 
Electrical Stimulation: A Practical Guide (4th Edition), 4th 
ed. Los Amigos Research Institute, Inc.) for the stimulation of 
the wrist and ?nger ?exors and extensors, and then moved 
around in small steps, until the point resulting with the stron 
gest motor response was identi?ed. During the probing, the 
stimulation frequency was set to 100 HZ, the pulse width to 
300 us, and the current amplitude to a comfortable level 
producing motor response (?exion/extension of the wrist/ 
?ngers). After the electrode location was determined, the 
self-adhesive stimulation electrodes were placed over the 
motor points. Stimulation frequency and current pulse width 
were set to 100 HZ and 300 us, and the pulse amplitude was 
adjusted to obtain a ?exion or extension of the joint. As 
muscle contractions induced by electrical stimulation over 
the muscle belly are known to be almost exclusively mediated 
by motor axon recruitment (A. J. Bergquist et al. (2012) 
Motor unit recruitment when neuromuscular electrical stimu 
lation is applied over a nerve trunk compared with a muscle 
belly: quadriceps femoris, Journal of applied physiology (Be 
thesda, Md.: 1985),vol. 113, no. 1,pp. 78-89;A. J. Bergquist 
et al. (2011) Motor unit recruitment when neuromuscular 
electrical stimulation is applied over a nerve trunk compared 
with a muscle belly: triceps surae, Journal of applied physi 
ology (Bethesda, Md.: 1985), vol. 110, no. 3, pp. 627-37) this 




Patient Age Tremor Frequency Tremor 
ID Gender [years] UPDRSII FTMS severity [HZ] etiology 
PDl Male 75 21 i Mild (l) 3.9 Parkinson 
disease 
PD2 Male 58 20 i Severe 3.3 Parkinson 
(3) disease 
PD3 Female 76 23 i Severe 4.2 Parkinson 
(3) disease 
PD4 Male 67 18 i Moderate 5 .2 Parkinson 
(2) disease 
ETl Female 73 i 49 Moderate 4.7 Essential 
(2—3) tremor 
ET2 Male 71 i 34 Moderate 4.5 Essential 
(2) tremor 
Notation: 
UPDRSII stands for Motor Section II ofthe Uni?ed Parkinson Disease Rating Scale; 
FTMS is Fahn-Tolosa-Marin tremor scale; 
Tremor severity was evaluated using the Whiget tremor scale. 






